DRUG DELIVERY
Heavy Metal Wonder
03/28/2019 | Jonathan James
An iridium-based photodynamic drug accumulates in cancer cell nuclei – and destroys them from within.
CANCER
The Story and Science Behind the "Mini-brain"
03/22/2019 | Simon Plummer
How iPSC-derived 3D organoids and high-throughput histology opens a new door to personalized medicine development and testing.
MICROBIOLOGY
Monitoring the Microbiome
03/25/2019 | Luke Turner
Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer.
CANCER
Anticipating NRAS Resistance
04/04/2018 | William Aryitey
How researchers are unraveling the mystery of melanoma drug resistance
This month we’re exploring all things Neuroscience – get involved with our #monthofneuro
This email was sent to
{~email~}
by
info@thetranslationalscientist.com
. To ensure delivery of emails to your inbox, please add
info@thetranslationalscientist.com
to your address book or safe sender list. To view online, please
click here
.
Create or manage your account here
Unsubscribe here
The Translational Scientist is a brand of Texere Publishing Limited
Texere Publishing Limited, Booths Park 1,
Chelford Road, Knutsford, WA16 8GS, UK
Registered Company Number: 08113419
Texere Publishing Inc., 115 Broadway, FL 5,
New York, NY 10006, USA
Federal Identification Number: 81-4613586